Parkinson’s Disease
We’ve Found There’s More to Explore Beyond Managing Parkinson’s Symptoms
Living with Parkinson’s means constantly adapting—medications, tremors, stiffness, balance, walking, sleep, and the uncertainty of what may come next.
And when you search for answers, the amount of information can be overwhelming. Some of it is encouraging. Some of it is confusing. Some of it makes claims that are difficult to know how to evaluate.
You shouldn’t have to sort through all of that alone.
We’ve put together a complimentary Parkinson’s Disease & Regenerative Medicine Research Collection to help you quickly explore some of the most relevant research—including human clinical studies and important newer developments that you may not have encountered.
Here are just a few reasons we think it is worth requesting:
Because you don’t want to miss something important.
A 2024 analysis of controlled clinical studies found measurable improvements in Parkinson’s rating scores following cell transplantation, while acknowledging that longer-term evidence is still limited.
Because the research is moving quickly.
In 2025, a randomized placebo-controlled trial of intravenous allogeneic MSCs reported improved motor function in the group receiving three infusions.
Because something remarkable is now being studied in humans: replacing dopamine-producing cells that Parkinson’s has taken away. Two 2025 clinical trials reported that transplanted stem-cell-derived dopamine-producing cells survived in the brain, with encouraging early motor findings.
And another area of research is asking a very different question: Could the therapeutic effects of regenerative cells come partly from the biological messages they release—rather than simply from replacing cells? Research into MSC secretome and extracellular vesicles is exploring neuroprotective, anti-inflammatory and neurotrophic effects.
The research is not a promise. But it is no longer just a theory, either.
We believe you deserve to see the evidence for yourself—including the encouraging findings, the limitations, and the studies that did not produce the hoped-for results.Request our complimentary Parkinson’s Disease & Regenerative Medicine Research Collection and use it as a starting point for your own research and conversations with your physicians.
No obligation. No pressure. Just information we believe you will not want to miss.
→ Request the Parkinson’s Complimentary Research Collection